Updated Jul 16, 2026 · Last SEC filing 2026-05-20
Opus Genetics, Inc. (IRD) has filed 14 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-05-20. 5 Form 8-K material event filings were reported by IRD in the last 90 days. 5 Form 144 notices of proposed sale were filed for IRD stock. InsiderAlpha tracks every IRD SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001228627 |
|---|
| Form 4 filings (90d) | 14 |
|---|---|
| Form 8-K filings (90d) | 5 |
| Form 144 notices (90d) | 5 |
| Latest Form 4 filing | 2026-05-20 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Foundation Fighting Blindness Retinal Degeneration Fund | Director | S — Open-market sale | 1.70M | $4.35 | $7.39M | SEC | |
| Jayagopal Ashwath | Chief Scientific & Dev. Ofc. | S — Open-market sale | 7.5K | $5.19 | $39K | SEC | |
| YERXA BENJAMIN R | President | S — Open-market sale | 7.5K | $5.24 | $39K | SEC | |
| Zaremba Rabourn Amy | Head of Fin. Quality Assurance | S — Open-market sale | 1.6K | $5.20 | $9K | SEC | |
| SCHACHLE JOSEPH K | Chief Operating Officer | S — Open-market sale | 4.7K | $5.22 | $25K | SEC | |
| Gagnon Robert E. | Chief Financial Officer | S — Open-market sale | 7.8K | $5.18 | $41K | SEC | |
| Magrath George | Chief Executive Officer | S — Open-market sale | 9.5K | $5.22 | $50K | SEC | |
| Rodgers Richard J | Insider | A — Grant or award | 24.4K | $0.00 | — | SEC | |
| Graves Adrienne L | Insider | A — Grant or award | 24.4K | $0.00 | — | SEC | |
| MANUSO JAMES S J | Insider | A — Grant or award | 24.4K | $0.00 | — | SEC | |
| Benton Susan | Insider | A — Grant or award | 24.4K | $0.00 | — | SEC | |
| Bennett Jean | Insider | A — Grant or award | 24.4K | $0.00 | — | SEC | |
| Gallagher Cam | Insider | A — Grant or award | 24.4K | $0.00 | — | SEC | |
| Ainsworth Sean | Insider | A — Grant or award | 24.4K | $0.00 | — | SEC | |
| Zaremba Rabourn Amy | Head of Fin. Quality Assurance | S — Open-market sale | 2.8K | $5.25 | $15K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Opus Genetics, Inc. (IRD). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Ainsworth Sean | 1 | — |
| Gallagher Cam | 1 | — |
| Rodgers Richard J | 1 | — |
| Benton Susan | 1 | — |
| Gagnon Robert E. | 1 | $41K |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in IRD insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live IRD dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.